← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

▼ SELL

$ Value

$2.3M

Shares

2,000,000

Price

$1

Filed

May 30

Insider

Name

Leonard Braden Michael

Title

CIK

0001373603

Roles

10% Owner

Transaction Details

Transaction Date

2025-05-28

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

3,749,432

Footnotes

BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. | The shares were sold in multiple transactions at an average price of $1.0324.

Filing Info

Accession No.

0001373604-25-000084

Form Type

4

Issuer CIK

0001880438

Leonard Braden Michael's History

Date Ticker Type Value
2025-12-04 ADVM $2.2M
2025-12-03 ADVM $930K
2025-12-02 ADVM $218K
2025-12-01 ADVM $1.3M
2025-10-03 ASTC $1.6M
2025-10-03 ASTC $53K
2025-05-30 ANTX $429K
2025-05-30 ANTX $7K
2025-05-28 ANTX $2.3M
2025-05-28 ANTX $116K

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03